RETRACTED: Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial.

ABSTRACT: RETRACTED ARTICLE: To date, no antiviral therapy has shown proven clinical effectiveness in treating patients with COVID-19. We assessed the efficacy of remdesivir in hospitalized Egyptian patients with COVID-19. Patients were randomly assigned at a 1:1 ratio to receive either remdesivir (200 mg on the first day followed by 100 mg daily for the next 9 days intravenously infused over 30-60 minutes) in addition to standard care or standard care alone. The primary outcomes were the length of hospital stay and mortality rate. The need for mechanical ventilation was assessed as a secondary outcome. Two hundred patients (100 in each group) completed the study and were included in the final analysis. The remdesivir group showed a significantly lower median duration of hospital stay (10 days) than

SUBMITTER: Abd-Elsalam S 

PROVIDER: S-EPMC8922517 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature